IHS Chemical Week

People & Business :: M&A

Otsuka Pharmaceutical to acquire US biotech firm Astex Pharmaceuticals

8:49 AM MDT | September 10, 2013 | Natasha Alperowicz

Otsuka Pharmaceutical Co. (Tokyo) and Astex Pharmaceuticals (Dublin, CA) have  announced that their boards of directors have unanimously approved a transaction under which Otsuka will acquire all of the outstanding shares of Astex for approximately $886 million. Otsuka intends to make a tender offer and expects to close the transaction early in the fourth quarter of 2013, subject to the satisfaction of customary closing conditions.   Astex is dedicated to the discovery and development of novel small molecule therapeutics with a particular focus on...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa